RxDoctor Payments Data

Matthew Recker, MD

Vascular & Interventional Radiology · Lewiston, MENPI 1164682324

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Sirtex Medical Inc at 46.3% of the total. Reporting peaked in 2019 at $1,268 and has fallen 86.5% since, to $172 in 2025.

$2,972in general payments, 2019–2025

Across 48 payments — averaging $61.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sirtex Medical Inc$1K
  • Boston Scientific$586
  • Terumo Medical Corporation$192
  • Medtronic$182
  • Argon Medical Devices, Inc.$160
  • Imperative Care, Inc$151
  • plus $328 from 4 others

What the payments were for

  • Food & beverage$2,972100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular & interventional radiology providers in Maineto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$72,703
Medicare patients
1,448
Services billed
1,982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate56$523
Cilostazol15$225

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Lewiston

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →